Immune Response Regulation
The interaction of cell surface receptors with secreted cytokines and with one another tightly controls the immune response, and several groups are investigating the mechanisms by which these interactions have regulatory effects. Understanding how specialised cells or anatomical regions, such as vascular endothelial cells or the epidermis, control and guide the immune response is another important area of research.
The pathogenesis of IBD depends on the interaction of effector T cells and APCs. APCs ingest the antigens that support the inflammatory response. Epitope is presented in the context of MHC class II as a result of antigen degradation within proteasomes. The CD4+ T cell and macrophage engage specifically with antigens when MHC classes II and the T-cell receptor (CD3) connect. The T cell must occur, but it is not enough to activate it. Because binding of CD3 to MHC class II without a co-stimulatory signal might result in energy or apoptosis, a second co-stimulatory signal is also required. Co-stimulatory signals of importance include TNF-TNF receptor, CD40-CD40 ligand, and B7-CD28 binding.
Related Conference of Immune Response Regulation
Immune Response Regulation Conference Speakers
Recommended Sessions
- Cancer
- Cancer Genetics and Cell Biology
- Cancer Immunology & Immunotherapy
- Cancer Pharmacology
- Cellular Adhesion, Migration, and Inflammation
- Clinical Immunology
- Computational Immunology
- Cytokines and Chemokine’s and Their Receptors
- Haematopoiesis and Immune System Development
- Immune Response Regulation
- Immunogenetics of Autoimmunity
- Immunopathogenic Mechanisms
- Lymphocyte Differentiation and Peripheral Maintenance
- Microbial Parasitic and Fungal Immunology
- Mucosal and Regional Immunology
- Radiation Oncology
- Technological Innovations in Immunology
- Therapeutic Approaches to Autoimmunity
- Transplantation Immunology
- Vaccines and Immunotherapy
- Veterinary and Comparative Immunology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)

